Trial Profile
Phase II trial of intravenous marizomib + dexamethasone for highly refractory multiple myeloma.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Mar 2014
Price :
$35
*
At a glance
- Drugs Marizomib (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 04 Mar 2014 New trial record